Transcend Capital Advisors’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$498K Buy
158,600
+2,543
+2% +$7.95K 0.03% 453
2026
Q1
$456K Buy
156,057
+63,065
+68% +$180K 0.04% 403
2025
Q4
$230K Buy
92,992
+29,964
+48% +$71.4K 0.02% 618
2025
Q3
$141K Buy
63,028
+28,430
+82% +$65K 0.01% 679
2025
Q2
$83.4K Buy
34,598
+24,579
+245% +$59.8K 0.01% 608
2025
Q1
$23.3K Sell
10,019
-20,326
-67% -$40.7K ﹤0.01% 601
2024
Q4
$56.1K Buy
30,345
+1,917
+7% +$4.24K ﹤0.01% 566
2024
Q3
$69.4K Buy
28,428
+6,097
+27% +$13.7K ﹤0.01% 611
2024
Q2
$45.8K Buy
+22,331
New +$50.9K ﹤0.01% 593
2023
Q4
– Sell
-11,565
Closed -$29.8K – 508
2023
Q3
$29.8K Buy
11,565
+1,563
+16% +$4.52K ﹤0.01% 483
2023
Q2
$31.8K Buy
+10,002
New +$29.4K ﹤0.01% 482

Other funds holding ABEV

Transcend Capital Advisors's ABEV Position: Q2 2026 in Review

Transcend Capital Advisors increased its Ambev (ABEV) stake by 1.6% in Q2 2026, buying an estimated $7.95K and bringing the position to 158,600 shares worth $498K. The position accounts for 0.03% of the portfolio, ranked #453.

Transcend Capital Advisors first reported a position in ABEV in Q2 2023 and has held it in 11 quarters since. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Transcend Capital Advisors held 158,600 shares of Ambev worth $498K as of Q2 2026.
  • Transcend Capital Advisors bought 2,543 Ambev shares in Q2 2026, an estimated $7.95K.
  • Ambev made up 0.03% of Transcend Capital Advisors's portfolio in Q2 2026, its #453 holding.
  • Transcend Capital Advisors first reported a position in Ambev in Q2 2023 and has held it in 11 quarters since.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Transcend Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.